Daytrana
Daytrana (formerly known as MethylPatch) is a medicinal patch marketed and developed under contract by Noven Pharmaceuticals that was approved in April 2006. In the literature, Daytrana is most commonly referred to as Methylphenidate Transdermal System (MTS).
DaytranaMethylphenidateTransdermal patchShire plcList of psychiatric medicationsNorepinephrine transporterRecreational drug useAttention deficit hyperactivity disorder management
Share this!